Updating the knowledge of hepatitis E: new variants and higher prevalence of anti-HEV in Argentina

Introduction. Hepatitis E is a disease of global distribution, with significant morbidity and mortality, whose scope and burden continue to emerge in low endemic countries.Material and methods. In 2012, we studied the prevalence of anti-HEV antibodies in 202 adult serum samples. We also analyzed sam...

Full description

Bibliographic Details
Main Authors: María S. Munné, Ph.D., Nancy R. Altabert, Lucio O. Otegui M., Sara N. Vladimirsky, Rita Moreiro, María P. Espul, Carlos Espul, Abelardo Manzur, Sonia S. Soto, Leonardo S. Brajterman, Jorge E. González
Format: Article
Language:English
Published: Elsevier 2014-09-01
Series:Annals of Hepatology
Subjects:
Online Access:http://www.sciencedirect.com/science/article/pii/S1665268119312487
id doaj-c875f88cf04548219356fe53bcd883fa
record_format Article
spelling doaj-c875f88cf04548219356fe53bcd883fa2021-06-09T05:53:49ZengElsevierAnnals of Hepatology1665-26812014-09-01135496502Updating the knowledge of hepatitis E: new variants and higher prevalence of anti-HEV in ArgentinaMaría S. Munné, Ph.D.0Nancy R. Altabert1Lucio O. Otegui M.2Sara N. Vladimirsky3Rita Moreiro4María P. Espul5Carlos Espul6Abelardo Manzur7Sonia S. Soto8Leonardo S. Brajterman9Jorge E. González10National Reference Laboratory of Viral Hepatitis. National Institute of Infectious Diseases “Carlos G. Malbran”. Ciudad Autónoma de Buenos Aires. Argentina; Correspondence and reprint request:National Reference Laboratory of Viral Hepatitis. National Institute of Infectious Diseases “Carlos G. Malbran”. Ciudad Autónoma de Buenos Aires. ArgentinaNational Reference Laboratory of Viral Hepatitis. National Institute of Infectious Diseases “Carlos G. Malbran”. Ciudad Autónoma de Buenos Aires. ArgentinaNational Reference Laboratory of Viral Hepatitis. National Institute of Infectious Diseases “Carlos G. Malbran”. Ciudad Autónoma de Buenos Aires. ArgentinaLaboratory. Pediatric Hospital J.P. Garrahan. Ciudad Autónoma de Buenos Aires. ArgentinaVeterinary Science Faculty. Juan Mazza University. Mendoza. ArgentinaVirology Division. Central Hospital. Mendoza. ArgentinaVirology Division. Central Hospital. Mendoza. ArgentinaNational Reference Laboratory of Viral Hepatitis. National Institute of Infectious Diseases “Carlos G. Malbran”. Ciudad Autónoma de Buenos Aires. ArgentinaNational Reference Laboratory of Viral Hepatitis. National Institute of Infectious Diseases “Carlos G. Malbran”. Ciudad Autónoma de Buenos Aires. ArgentinaNational Reference Laboratory of Viral Hepatitis. National Institute of Infectious Diseases “Carlos G. Malbran”. Ciudad Autónoma de Buenos Aires. ArgentinaIntroduction. Hepatitis E is a disease of global distribution, with significant morbidity and mortality, whose scope and burden continue to emerge in low endemic countries.Material and methods. In 2012, we studied the prevalence of anti-HEV antibodies in 202 adult serum samples. We also analyzed samples from 143 patients with acute non-A-C hepatitis from January 2011 to December 2013. Acute HEV infections were diagnosed with anti-HEV IgM and/or HEV RNA. HEV RNA was also investigated in 94 swine fecal samples. HEV RNA was sequenced and characterized.Results. We found higher values of prevalence than those previously reported in the 1990s. The overall prevalence of anti-HEV IgG antibodies was 15.4%. The prevalence was 10.6% in the 123 adults voluntarily screened on World Hepatitis Day 2012 in Buenos Aires city and 14.8, 16.7 and 35.7% respectively in the smaller groups of healthcare workers, blood donors and HIV-positive patients from different regions of the country. Nine acute HEV infections were diagnosed in the three years analyzed. We characterized new human variants of subgenotype 3a and 3i. New subgenotype 3i variants were found in swine from two distant provinces closely related to the human ones.Conclusions. These results enlarge the knowledge of HEV and contribute with new information. However, higher values of prevalence found in small groups need to be confirmed in larger studies. Many aspects of the spectrum of the disease and the reservoirs and routes of transmission are still unknown and thus deserve additional research.http://www.sciencedirect.com/science/article/pii/S1665268119312487DiagnosisMolecular epidemiologyGenotypeHEV RNAAcute infection
collection DOAJ
language English
format Article
sources DOAJ
author María S. Munné, Ph.D.
Nancy R. Altabert
Lucio O. Otegui M.
Sara N. Vladimirsky
Rita Moreiro
María P. Espul
Carlos Espul
Abelardo Manzur
Sonia S. Soto
Leonardo S. Brajterman
Jorge E. González
spellingShingle María S. Munné, Ph.D.
Nancy R. Altabert
Lucio O. Otegui M.
Sara N. Vladimirsky
Rita Moreiro
María P. Espul
Carlos Espul
Abelardo Manzur
Sonia S. Soto
Leonardo S. Brajterman
Jorge E. González
Updating the knowledge of hepatitis E: new variants and higher prevalence of anti-HEV in Argentina
Annals of Hepatology
Diagnosis
Molecular epidemiology
Genotype
HEV RNA
Acute infection
author_facet María S. Munné, Ph.D.
Nancy R. Altabert
Lucio O. Otegui M.
Sara N. Vladimirsky
Rita Moreiro
María P. Espul
Carlos Espul
Abelardo Manzur
Sonia S. Soto
Leonardo S. Brajterman
Jorge E. González
author_sort María S. Munné, Ph.D.
title Updating the knowledge of hepatitis E: new variants and higher prevalence of anti-HEV in Argentina
title_short Updating the knowledge of hepatitis E: new variants and higher prevalence of anti-HEV in Argentina
title_full Updating the knowledge of hepatitis E: new variants and higher prevalence of anti-HEV in Argentina
title_fullStr Updating the knowledge of hepatitis E: new variants and higher prevalence of anti-HEV in Argentina
title_full_unstemmed Updating the knowledge of hepatitis E: new variants and higher prevalence of anti-HEV in Argentina
title_sort updating the knowledge of hepatitis e: new variants and higher prevalence of anti-hev in argentina
publisher Elsevier
series Annals of Hepatology
issn 1665-2681
publishDate 2014-09-01
description Introduction. Hepatitis E is a disease of global distribution, with significant morbidity and mortality, whose scope and burden continue to emerge in low endemic countries.Material and methods. In 2012, we studied the prevalence of anti-HEV antibodies in 202 adult serum samples. We also analyzed samples from 143 patients with acute non-A-C hepatitis from January 2011 to December 2013. Acute HEV infections were diagnosed with anti-HEV IgM and/or HEV RNA. HEV RNA was also investigated in 94 swine fecal samples. HEV RNA was sequenced and characterized.Results. We found higher values of prevalence than those previously reported in the 1990s. The overall prevalence of anti-HEV IgG antibodies was 15.4%. The prevalence was 10.6% in the 123 adults voluntarily screened on World Hepatitis Day 2012 in Buenos Aires city and 14.8, 16.7 and 35.7% respectively in the smaller groups of healthcare workers, blood donors and HIV-positive patients from different regions of the country. Nine acute HEV infections were diagnosed in the three years analyzed. We characterized new human variants of subgenotype 3a and 3i. New subgenotype 3i variants were found in swine from two distant provinces closely related to the human ones.Conclusions. These results enlarge the knowledge of HEV and contribute with new information. However, higher values of prevalence found in small groups need to be confirmed in larger studies. Many aspects of the spectrum of the disease and the reservoirs and routes of transmission are still unknown and thus deserve additional research.
topic Diagnosis
Molecular epidemiology
Genotype
HEV RNA
Acute infection
url http://www.sciencedirect.com/science/article/pii/S1665268119312487
work_keys_str_mv AT mariasmunnephd updatingtheknowledgeofhepatitisenewvariantsandhigherprevalenceofantihevinargentina
AT nancyraltabert updatingtheknowledgeofhepatitisenewvariantsandhigherprevalenceofantihevinargentina
AT lucioooteguim updatingtheknowledgeofhepatitisenewvariantsandhigherprevalenceofantihevinargentina
AT saranvladimirsky updatingtheknowledgeofhepatitisenewvariantsandhigherprevalenceofantihevinargentina
AT ritamoreiro updatingtheknowledgeofhepatitisenewvariantsandhigherprevalenceofantihevinargentina
AT mariapespul updatingtheknowledgeofhepatitisenewvariantsandhigherprevalenceofantihevinargentina
AT carlosespul updatingtheknowledgeofhepatitisenewvariantsandhigherprevalenceofantihevinargentina
AT abelardomanzur updatingtheknowledgeofhepatitisenewvariantsandhigherprevalenceofantihevinargentina
AT soniassoto updatingtheknowledgeofhepatitisenewvariantsandhigherprevalenceofantihevinargentina
AT leonardosbrajterman updatingtheknowledgeofhepatitisenewvariantsandhigherprevalenceofantihevinargentina
AT jorgeegonzalez updatingtheknowledgeofhepatitisenewvariantsandhigherprevalenceofantihevinargentina
_version_ 1721388869483495424